[Retrospective evaluation of the results of female patients of childbearing age at a microbiology laboratory for screening Toxoplasma gondii in Kocaeli Derince].
OBJECTIVE
The aim of the previous study was to retrospectively analyze the seropositive rate of Toxoplasma among women of childbearing age who were suspected to have toxoplasmosis at the Microbiology Laboratory of Kocaeli Derince Education and Research Hospital.


METHODS
The presence of Toxoplasma antibodies (IgM, IgG) with Axsym commercial ELISA kits between January 2009 and February 2011 and the presence of Toxoplasma antibodies (IgM, IgG) with Architect commercial ELISA kit between February 2011 and June 2012 were investigated in a total of 943 sera from women included in the study.


RESULTS
The seropositive rate of anti-Toxoplasma IgG and IgM in the study was 28.5% (N=741), 0.9% (N=898), respectively. Additionally, 10 samples (1.3%) were considered as border-line for IgG antibodies and 4 samples (0.4%) for IgM antibodies against T. gondii.


CONCLUSIONS
In general, 70.2% of women in the study were seronegative for anti-Toxoplasma IgG antibodies; it can be concluded that most of them were sensitive to a newly acquired infection, and that their babies were at risk of congenital toxoplasmosis in case of a possible pregnancy. In conclusion, the present study suggested that toxoplasmosis was still an emerging public health problem in study area, and particularly, women of reproductive age should be warned and informed about toxoplasmosis.
Kocaeli Derince Eğitim ve Araştırma Hastanesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Kocaeli, Türkiye. vesileyazici@yahoo.com.
Vesile
V
Yazıcı
Ahmet
A
Kale
Erdoğan
E
Malatyalı
Hatice
H
Ertabaklar
D000293:Adolescent; D000328:Adult; D000913:Antibodies, Protozoan / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D008875:Middle Aged; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000517:prevention & control; D012189:Retrospective Studies; D016036:Seroepidemiologic Studies; D014122:Toxoplasma / Q000276:immunology*; D014123:Toxoplasmosis / Q000453:epidemiology* / Q000276:immunology; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control; D014421:Turkey / Q000453:epidemiology; D055815:Young Adult
D000913:Antibodies, Protozoan; D007074:Immunoglobulin G; D007075:Immunoglobulin M